MPM BioImpact’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-783,242
| Closed | -$11M | – | 46 |
|
|
2024
Q2 | $11M | Sell |
783,242
-87,907
| -10% | -$1.24M | 1.71% | 20 |
|
|
2024
Q1 | $14.7M | Buy |
871,149
+206,163
| +31% | +$3.48M | 2.37% | 13 |
|
|
2023
Q4 | $9.39M | Buy |
664,986
+762
| +0.1% | +$10.8K | 2.2% | 18 |
|
|
2023
Q3 | $6.84M | Buy |
664,224
+279,234
| +73% | +$2.88M | 1.83% | 20 |
|
|
2023
Q2 | $6.34M | Buy |
+384,990
| New | +$6.34M | 1.28% | 25 |
|
|
2022
Q4 | – | Sell |
-412,363
| Closed | -$2.07M | – | 35 |
|
|
2022
Q3 | $2.07M | Hold |
412,363
| – | – | 0.49% | 31 |
|
|
2022
Q2 | $1.01M | Hold |
412,363
| – | – | 0.28% | 35 |
|
|
2022
Q1 | $2.82M | Buy |
412,363
+37,037
| +10% | +$253K | 0.76% | 31 |
|
|
2021
Q4 | $3.03M | Sell |
375,326
-24,674
| -6% | -$199K | 0.55% | 29 |
|
|
2021
Q3 | $3.92M | Buy |
+400,000
| New | +$3.92M | 0.61% | 30 |
|